Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to ...

Earlier Monday, the U.S. FDA approved Bausch + Lomb's (BlCO) eye surgery product, the Teneo Excimer Laser Platform, to conduct a surgical procedure called keratomileusis (LASIK).

(Reuters) - Bausch + Lomb is exploring a potential sale among other options, it said on Thursday, in a move that would help ...

Bausch + Lomb sells contact lenses, eye drops and other products that generate a steady revenue stream. Bausch Health’s main drug, the gut antibiotic Xifaxan, will likely face generic ...

Shares of Bausch Health and subsidiary Bausch + Lomb fell sharply Wednesday after a report by the Financial Times suggested that Blackstone might back out of a joint bid to acquire the eye-health ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an ...

Emergent appoints former Bausch + Lomb CEO to head company February 21, 2024 The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that closely ...

Elios Vision former chairman and CEO Elliot Friedman said: “Bausch + Lomb’s extensive reach in cataract surgery will introduce ELIOS to a broader range of eye care professionals and help ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global leader in eye health products with a market capitalization of $6.55 billion, has been navigating a complex market landscape in 2024. The ...

Bausch + Lomb Corp (NYSE:BLCO; TSX:BLCO), a global leader in eye health products, has recently experienced a mix of positive developments and challenges that have caught the attention of investors ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global leader in eye health products with a market capitalization of $6.55 billion, has been navigating a complex market landscape in 2024.

Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. That process is ongoing. No decision has been reached to proceed with any ...